戻る Agenda
Session 7 Track 3: Policy Updates: The Evolution of Customer-Facing Medical Roles
Session Chair(s)
Kathryn Bucci, PharmD
Medical Governance Lead
Pfizer, Inc., United States
Ed Cunningham, PharmD
Sunovion Pharmaceuticals, Inc., United States
Recent court rulings and environmental trends are shaping what pharma can communicate about their products. The current FDA rules pose challenges and the need for clarification as companies work to interpret these rules. As the demand for medical information continues to increase, this session will discuss how the interpretation and application of these rules is expected to further evolve the role of customer-facing medical teams.
Learning Objective : At the conclusion of this session, participants should be able to:
- Prepare an overview of recent court rulings regarding manufacturers’ ability to communicate
- Describe the current challenges in FDA rules and how they influence pharma companies
- Explain how companies are interpreting and applying the rules to customer-facing medical roles
- Describe what the industry can do to advance capabilities and move field-based medical roles forward
Speaker(s)
Speaker
Michelle Drozd
Pharmaceutical Research and Manufacturers of America (PhRMA), United States
Deputy Vice President, Policy & Research
Speaker
Michael S. Labson, JD
Covington & Burling LLP, United States
Partner